RELI Group Wins $60M Contract for Medicare Drug Price Oversight

The Centers for Medicare and Medicaid Services has awarded RELI Group a 5-year, $60 million contract to support monitoring, oversight, compliance and auditing for the Medicare Drug Price Negotiation Program. This contract adds to RELI Group’s extensive portfolio of over 20 active CMS contracts, and the company is honored to support CMS in its efforts to improve transparency and accountability in Medicare drug pricing.